theophylline has been researched along with Pneumonia in 29 studies
Pneumonia: Infection of the lung often accompanied by inflammation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Theophylline disposition (clearance, volume of distribution, and half-life) was measured in 31 normal volunteers and 26 acutely ill patients with airway obstruction within 24 hours of hospital admission and again when intravenous aminophylline was discontinued 2 to 10 days later." | 7.66 | Theophylline disposition in acutely ill hospitalized patients. The effect of smoking, heart failure, severe airway obstruction, and pneumonia. ( Costello, J; Hopewell, P; Powell, JR; Riegelman, S; Sheiner, LB; Vozeh, S, 1978) |
| " The patient later developed pneumonia and was enrolled in a study of nosocomial acquired pneumonia involving clinafloxacin versus ceftazidime." | 5.08 | Clinafloxacin-theophylline drug interaction. ( Matuschka, PR; Vissing, RS, 1995) |
| "In order to determine the efficacy and safety of the new quinolone ofloxacin in the treatment of chronic lower respiratory disease, 674 patients (353 with chronic bronchitis, 212 with community-acquired pneumonia and 109 with hospital-acquired pneumonia) were treated with ofloxacin 200 mg twice a day." | 3.68 | Ofloxacin in lower respiratory tract infections. ( Petermann, W, 1991) |
| " The infection coincided with neutropenia resulting from pyrazolone treatment." | 3.67 | Trichosporon beigelii pneumonia in a neutropenic patient. ( Borras, R; Chiner, E; Franco, J; Marin, J, 1989) |
| "Theophylline disposition (clearance, volume of distribution, and half-life) was measured in 31 normal volunteers and 26 acutely ill patients with airway obstruction within 24 hours of hospital admission and again when intravenous aminophylline was discontinued 2 to 10 days later." | 3.66 | Theophylline disposition in acutely ill hospitalized patients. The effect of smoking, heart failure, severe airway obstruction, and pneumonia. ( Costello, J; Hopewell, P; Powell, JR; Riegelman, S; Sheiner, LB; Vozeh, S, 1978) |
| "Theophylline is a difficult drug to use clinically, requiring careful titration and routine plasma monitoring due to the risk of toxic side effects, such as cardiovascular and central nervous system adverse events, with dose adjustments required in many patients, including smokers, the elderly and some patients on concomitant medications." | 2.42 | PDE4 inhibitors in COPD--a more selective approach to treatment. ( Vignola, AM, 2004) |
| "Doxofylline is a xanthine drug that has been used as a treatment for respiratory diseases for more than 30 years." | 1.40 | Doxofylline, a novofylline inhibits lung inflammation induced by lipopolysacharide in the mouse. ( Man, F; Page, CP; Riffo-Vasquez, Y, 2014) |
| "In the second model, in blood of COPD-patients and healthy controls ex vivo pre-incubated with a physiological concentration of 1,7-dimethylxanthine (10microM), LPS-induced production of the cytokines IL-6 and TNF-alpha was significantly suppressed." | 1.36 | Inhibition of acute pulmonary and systemic inflammation by 1,7-dimethylxanthine. ( Bast, A; Brauers, K; Geraets, L; Haegens, A; Hageman, GJ; Vernooy, JH; Weseler, AR; Wouters, EF, 2010) |
| "582 case records of patients with cancer of the larynx have been examined for associated bronchopulmonary disease." | 1.30 | [Bronchopulmonary complications in patients with laryngeal cancer: features of preoperative care]. ( Malinin, AN; Smetanin, IG, 1998) |
| "Enoxacin is a safe and effective alternative to parenteral treatment of lower respiratory tract infections." | 1.27 | Enoxacin in the treatment of lower respiratory tract infections. ( Arnaud, A; Frances, Y; Nourrit, J; Philip-Joet, F, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (48.28) | 18.7374 |
| 1990's | 7 (24.14) | 18.2507 |
| 2000's | 5 (17.24) | 29.6817 |
| 2010's | 3 (10.34) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Riffo-Vasquez, Y | 2 |
| Venkatasamy, R | 1 |
| Page, CP | 2 |
| Man, F | 1 |
| Stiefelhagen, P | 2 |
| Geraets, L | 1 |
| Haegens, A | 1 |
| Weseler, AR | 1 |
| Brauers, K | 1 |
| Vernooy, JH | 1 |
| Wouters, EF | 1 |
| Bast, A | 1 |
| Hageman, GJ | 1 |
| Balfour-Lynn, IM | 1 |
| Elborn, JS | 1 |
| FISCHER, W | 1 |
| KRUMBHOLZ, S | 1 |
| TAUB, SJ | 1 |
| KUSZTOS, D | 1 |
| HAFFNER, Z | 1 |
| Vignola, AM | 1 |
| Misawa, D | 1 |
| Ohshima, K | 1 |
| Watanabe, M | 1 |
| Asai, K | 1 |
| Ino, T | 1 |
| Ueda, M | 1 |
| Morgan, WJ | 1 |
| Taussig, LM | 1 |
| Nikki, P | 1 |
| Meretoja, O | 1 |
| Valtonen, V | 1 |
| Mäkeläinen, A | 1 |
| Saikku, P | 1 |
| Mattila, S | 1 |
| Taskinen, E | 1 |
| Flenley, DC | 1 |
| Matuschka, PR | 1 |
| Vissing, RS | 1 |
| Jaspersen, D | 1 |
| Lilley, LL | 1 |
| Guanci, R | 1 |
| Smetanin, IG | 1 |
| Malinin, AN | 1 |
| Vozeh, S | 2 |
| Powell, JR | 2 |
| Riegelman, S | 2 |
| Costello, JF | 1 |
| Sheiner, LB | 2 |
| Hopewell, PC | 1 |
| Hopewell, P | 1 |
| Costello, J | 1 |
| Vaquero Peña, MA | 1 |
| Martín Arias, LH | 1 |
| Saldana Garrido, D | 1 |
| Carvajal García-Pando, A | 1 |
| Petermann, W | 1 |
| Boner, AL | 1 |
| Piacentini, GL | 1 |
| Peroni, DG | 1 |
| Bacchini, P | 1 |
| Franco, L | 1 |
| Velo, G | 1 |
| Bellanti, JA | 1 |
| Marin, J | 1 |
| Chiner, E | 1 |
| Franco, J | 1 |
| Borras, R | 1 |
| Philip-Joet, F | 1 |
| Nourrit, J | 1 |
| Frances, Y | 1 |
| Arnaud, A | 1 |
| Späth, G | 1 |
| Marx, HH | 1 |
| Pulyk, PM | 1 |
| Levine, ER | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy Of Doxophylline As A Sparing Treatment For Inhaled Corticosteroids In Mexican Children With Asthma[NCT03879590] | Phase 3 | 60 participants (Anticipated) | Interventional | 2019-05-31 | Not yet recruiting | ||
| [NCT00005279] | 0 participants | Observational | 1971-06-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for theophylline and Pneumonia
| Article | Year |
|---|---|
"CF asthma": what is it and what do we do about it?
Topics: Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Asthma; Bronchial Hyperreactivity; Bronchodila | 2002 |
PDE4 inhibitors in COPD--a more selective approach to treatment.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Aminopyridines; Benzamides; Bronchodilator Agents; Carboxylic A | 2004 |
The chronic bronchitis complex in children.
Topics: Adrenergic beta-Agonists; Adult; Age Factors; Air Pollution; Anti-Bacterial Agents; Asthma; Bronchit | 1984 |
Recent advances in respiratory medicine.
Topics: Adult; Aged; Anti-Bacterial Agents; Asthma; Bronchitis; Cephalosporins; Child; Humans; Immunosuppres | 1983 |
[Reflux associated respiratory tract diseases].
Topics: Bronchiectasis; Bronchitis; Bronchodilator Agents; Chronic Disease; Esophagogastric Junction; Gastro | 1996 |
[The acute respiratory insufficiency].
Topics: Acute Disease; Asthma; Blood Gas Analysis; Bronchitis; Butyrates; Chronic Disease; Cortisone; Electr | 1972 |
1 trial available for theophylline and Pneumonia
| Article | Year |
|---|---|
Clinafloxacin-theophylline drug interaction.
Topics: Aged; Anti-Infective Agents; Cross Infection; Delayed-Action Preparations; Drug Interactions; Drug M | 1995 |
22 other studies available for theophylline and Pneumonia
| Article | Year |
|---|---|
Steroid sparing effects of doxofylline.
Topics: Animals; Bronchodilator Agents; Dexamethasone; Disease Models, Animal; Dose-Response Relationship, D | 2018 |
Doxofylline, a novofylline inhibits lung inflammation induced by lipopolysacharide in the mouse.
Topics: Animals; Anti-Inflammatory Agents; Bronchodilator Agents; Cell Movement; Disease Models, Animal; Dos | 2014 |
[COPD and pneumonia therapy in the elderly. What is different in aging lungs].
Topics: Adrenal Cortex Hormones; Adrenergic beta-Agonists; Aged; Bronchodilator Agents; Comorbidity; Dose-Re | 2008 |
[Pulmonary diseases in pregnancy. What drugs are permitted?].
Topics: Abnormalities, Drug-Induced; Adrenal Cortex Hormones; Anti-Bacterial Agents; Antitubercular Agents; | 2009 |
Inhibition of acute pulmonary and systemic inflammation by 1,7-dimethylxanthine.
Topics: Administration, Oral; Aged; Animals; Anti-Inflammatory Agents; Benzamides; Case-Control Studies; Cyt | 2010 |
[CONSIDERATIONS ON THE RELATION BETWEEN CEREBRAL AND PULMONARY BLOOD FLOW UNDER THE INFLUENCE OF ANESTHESIA AND BRAIN SURGERY (WITH USE OF A THEOPHYLLINE- PYRAZOLONE COMBINATION PREPARATION)].
Topics: Aminopyrine; Anesthesia; Brain; Brain Neoplasms; Bronchitis; Bronchopneumonia; Cerebrovascular Circu | 1963 |
THE DIAGNOSIS AND TREATMENT OF ASTHMA IN THE ELDERLY.
Topics: Aerosols; Aged; Asthma; Betamethasone; Bronchiectasis; Bronchitis; Dexamethasone; Dyspnea; Dyspnea, | 1964 |
[USE OF PERIPHERIN-HOMBURG IN CIRCULATORY DISEASES OF THE BRAIN].
Topics: Brain; Cardiovascular Diseases; Cerebral Hemorrhage; Cerebrovascular Disorders; Ephedrine; Humans; I | 1964 |
[Rhabdomyolysis: case report of 11 patients].
Topics: Adult; Aged; Enteritis; Female; Humans; Hypokinesia; Influenza A virus; Influenza, Human; Male; Midd | 2005 |
Severe bronchiolitis probably caused by varicella-zoster virus.
Topics: Adult; Biopsy; Bronchi; Bronchiolitis, Viral; Chickenpox; Herpesvirus 3, Human; Humans; Hypercapnia; | 1982 |
Avoiding adverse reactions.
Topics: Antacids; Anti-Infective Agents; Asthma; Bronchodilator Agents; Ciprofloxacin; Drug Interactions; Hu | 1996 |
[Bronchopulmonary complications in patients with laryngeal cancer: features of preoperative care].
Topics: Acid-Base Equilibrium; Antibiotic Prophylaxis; Bronchitis; Bronchodilator Agents; Histamine Antagoni | 1998 |
Changes in theophylline clearance during acute illness.
Topics: Acute Disease; Aged; Airway Obstruction; Female; Heart Failure; Humans; Male; Metabolic Clearance Ra | 1978 |
Theophylline disposition in acutely ill hospitalized patients. The effect of smoking, heart failure, severe airway obstruction, and pneumonia.
Topics: Acute Disease; Adult; Aged; Airway Obstruction; Asthma; Bronchitis; Chronic Disease; Female; Half-Li | 1978 |
[A case of galactorrhea in a patient treated with theophylline].
Topics: Adult; Female; Galactorrhea; Humans; Pneumonia; Theophylline | 1992 |
Ofloxacin in lower respiratory tract infections.
Topics: Bacterial Infections; Bronchitis; Chronic Disease; Cross Infection; Drug Administration Schedule; Dr | 1991 |
Theophylline inhibition of BCG-induced pulmonary inflammatory responses.
Topics: Animals; BCG Vaccine; Bronchoalveolar Lavage Fluid; Lung; Male; Pneumonia; Rats; Rats, Inbred Strain | 1990 |
Trichosporon beigelii pneumonia in a neutropenic patient.
Topics: Agranulocytosis; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Humans; Lung Diseases, Fungal; Mal | 1989 |
Enoxacin in the treatment of lower respiratory tract infections.
Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Bronchiectasis; Bronchitis; Chronic Disease; Drug | 1988 |
[What is certain in the therapy of unspecific lung diseases?].
Topics: Anti-Bacterial Agents; Asthma; Bronchiectasis; Empyema; Humans; Lung Abscess; Lung Diseases; Lung Di | 1969 |
[Diaphylline in the combined treatment of pneumonia in children].
Topics: Humans; Infant; Pneumonia; Theophylline | 1968 |
An effective oral medication for long term bronchodilation.
Topics: Adult; Asthma; Bronchitis; Humans; Middle Aged; Pneumonia; Pulmonary Emphysema; Theophylline | 1965 |